The neurologic benefit from EPO treatment as supportive therapy has been suggested specifically for acute stroke [205], chronic schizophrenic patients [206,207], patients with type 1 diabetes mellitus [208] and carbon monoxide poisoning [209], and for mood symptom and depression associated memory dysfunction possibly relating to hippocampus-dependent memory [210]. The gene discussed is EPO; the disease is type 1 diabetes mellitus.